Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest announcement is out from Raily Aesthetic Medicine International Holdings Limited ( (HK:2135) ).
Raily Aesthetic Medicine International Holdings Limited announced the termination of its contractual arrangements with Hangzhou Beilifeier, as the latter shifts its strategic focus towards the sales of aesthetic medical equipment products. This move comes after the cessation of Hangzhou Beilifeier’s aesthetic medical services and the application for a medical device business license, removing restrictions on foreign ownership and allowing Raily to transfer equity interests and unwind previous agreements.
More about Raily Aesthetic Medicine International Holdings Limited
Raily Aesthetic Medicine International Holdings Limited, incorporated in the Cayman Islands, operates in the aesthetic medical industry. The company focuses on providing aesthetic medical services and selling aesthetic medical equipment products in the People’s Republic of China.
Average Trading Volume: 423,632
Technical Sentiment Signal: Sell
Current Market Cap: HK$69.63M
For detailed information about 2135 stock, go to TipRanks’ Stock Analysis page.